Compare CANG & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CANG | LNSR |
|---|---|---|
| Founded | 2010 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical Electronics |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.5M | 106.6M |
| IPO Year | 2018 | 2005 |
| Metric | CANG | LNSR |
|---|---|---|
| Price | $2.02 | $7.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $3.00 | ★ $10.00 |
| AVG Volume (30 Days) | ★ 489.9K | 70.5K |
| Earning Date | 05-14-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.61 |
| Revenue | N/A | ★ $58,435,000.00 |
| Revenue This Year | $428.72 | $10.06 |
| Revenue Next Year | $18.39 | $41.48 |
| P/E Ratio | ★ N/A | $11.60 |
| Revenue Growth | N/A | ★ 9.24 |
| 52 Week Low | $0.17 | $4.95 |
| 52 Week High | $4.92 | $12.94 |
| Indicator | CANG | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | 50.09 | 41.94 |
| Support Level | $1.82 | $5.17 |
| Resistance Level | $2.36 | $8.73 |
| Average True Range (ATR) | 0.28 | 0.33 |
| MACD | -0.02 | -0.17 |
| Stochastic Oscillator | 23.53 | 13.66 |
Cango Inc is a Bitcoin mining company with a vision to establish an integrated, world-wide infrastructure platform capable of powering the future digital economy. The operations are divided into two reportable segments (i) Bitcoin Mining Business and (ii) International Automobile Trading Business. The Company's mining operations span over 40 sites across North America, the Middle East, South America, and East Africa. Since entering the digital asset space in November 2024, Cango has activated pilot projects in both integrated energy solutions and distributed AI computing. In parallel, Cango continues to operate an online international used car export business through its subsidiary.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.